Concert Genetics
Latest round
- Series B
Last raised
- Mar 2014
Total raised
- $3M
Investors
- 5
About Concert Genetics
Concert Genetics, Inc.Founded in 2010 and headquartered in Nashville, US, Concert Genetics specializes in payment solutions for precision health diagnostics. The company has not undergone notable pivots or changes and operates independently. The CEO, Rob Metcalf, has a history of leadership within healthcare technology.Concert offers an integrated platform designed to enhance payment accuracy in precision health diagnostics. Its core product harmonizes clinical guidelines, coding, policy, and payment rules for automation, catering to health plans, hospitals, health systems, and laboratories. The solution addresses challenges in the fast-evolving diagnostics landscape, ensuring healthcare organizations can navigate payment complexities effectively.Concert generates revenue through partnerships and subscription models with healthcare organizations, focusing on the licensing of its cloud-based platform. This platform assists clients in managing test orders and reimbursement processes while integrating into existing workflows. Concert's offerings, including the test order management system and GTU® Test Identifier, enhance insurance alignment and clinical stewardship. The company is anticipated to focus on developing new products with specific functionalities to improve payment accuracy and efficiency. Future expansions are likely to target additional regions in the US, where the demand for precision health services is significantly increasing.
Who invested in Concert Genetics
5 investors across 4 rounds
See all investors in Concert Genetics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Concert Genetics
Who invested in Concert Genetics?
Concert Genetics has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Concert Genetics raised?
Concert Genetics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Concert Genetics last raise money?
Concert Genetics's most recent round on record is a Series B, in Mar 2014.
What does Concert Genetics do?
Concert Genetics is a healthcare it company.
Where is Concert Genetics headquartered?
Concert Genetics is headquartered in Nashville, US.
Which VCs invest in companies like Concert Genetics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Concert Genetics's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Concert Genetics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.